Dalriada Drug Discovery Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 71

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Dalriada Drug Discovery General Information

Description

Provider of integrated drug discovery services intended for biotechnology and pharmaceutical companies. The company's turnkey model utilizes medicinal chemistry, biological research, and a proprietary live-cell proteomics platform to accelerate the development of small-molecule therapies from initial concept through lead optimization and clinical evaluation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2820 Argentia Road
  • Unit 8-9
  • Mississauga, Ontario L5N 8G4
  • Canada
+1 (905)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2820 Argentia Road
  • Unit 8-9
  • Mississauga, Ontario L5N 8G4
  • Canada
+1 (905)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dalriada Drug Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-Aug-2026 Completed Generating Revenue
9. Grant 13-Nov-2020 Completed Generating Revenue
8. Grant 06-Feb-2018 Completed Generating Revenue
7. Early Stage VC (Series A) 02-Jun-2017 Completed Generating Revenue
6. Angel (individual) Completed Generating Revenue
5. Accelerator/Incubator 06-Apr-2017 Completed Generating Revenue
4. Grant 04-Apr-2017 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2017 $74.8K $74.8K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Dalriada Drug Discovery’s complete valuation and funding history, request access »

Dalriada Drug Discovery Patents

Dalriada Drug Discovery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3113532-A1 Pentafluorophenyl sulfonamide compounds, compositions and uses thereof Inactive 21-Sep-2017
EP-3684754-A1 Pentafluorophenyl sulfonamide compounds, compositions and uses thereof Inactive 21-Sep-2017
EP-3684754-A4 Pentafluorophenyl sulfonamide compounds, compositions and uses thereof Inactive 21-Sep-2017
US-20200277268-A1 Pentafluorophenyl sulfonamide compounds, compositions and uses thereof Inactive 21-Sep-2017
WO-2019056120-A1 Pentafluorophenyl sulfonamide compounds, compositions and uses thereof Inactive 21-Sep-2017 C07C311/20
To view Dalriada Drug Discovery’s complete patent history, request access »

Dalriada Drug Discovery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dalriada Drug Discovery Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Toronto University Minority
To view Dalriada Drug Discovery’s complete investors history, request access »

Dalriada Drug Discovery FAQs

  • When was Dalriada Drug Discovery founded?

    Dalriada Drug Discovery was founded in 2016.

  • Where is Dalriada Drug Discovery headquartered?

    Dalriada Drug Discovery is headquartered in Mississauga, Canada.

  • What is the size of Dalriada Drug Discovery?

    Dalriada Drug Discovery has 71 total employees.

  • What industry is Dalriada Drug Discovery in?

    Dalriada Drug Discovery’s primary industry is Drug Discovery.

  • Is Dalriada Drug Discovery a private or public company?

    Dalriada Drug Discovery is a Private company.

  • What is Dalriada Drug Discovery’s current revenue?

    The current revenue for Dalriada Drug Discovery is .

  • How much funding has Dalriada Drug Discovery raised over time?

    Dalriada Drug Discovery has raised $1.51M.

  • Who are Dalriada Drug Discovery’s investors?

    University of Toronto has invested in Dalriada Drug Discovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process